TPTamsin Kate Phillips

Tamsin Kate Phillips

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tamsin Kate Phillips has a total of 182 co-authors. Here are the top co-authors by number of shared publications:

  • Landon Myer

    University of Cape Town

    37 shared publications
  • Allison Zerbe

    Mailman School of Public Health ICAP at Columbia University Columbia University New York NY USA

    35 shared publications
  • Elaine J. Abrams

    Mailman School of Public Health, ICAP at Columbia University, Columbia University, New York, USA

    30 shared publications
  • Landon Myer

    Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa

    25 shared publications
  • Kirsty Brittain

    Division of Epidemiology and Biostatistics School of Public Health and Family Medicine University of Cape Town Cape Town South Africa

    23 shared publications
  • Kate Clouse

    Health Economics and Epidemiology Research Office, University of the Witwatersrand, Johannesburg, South Africa

    15 shared publications

Latest Publications

  • Improved Pregnancy Viral Load Monitoring but Persistent Postpartum Gaps After Guideline Changes: A Population-Based Analysis in the Western Cape, South Africa (2018–2024)

    by Kim Anderson, Emma Kalk, Tamsin Kate Phillips, Nisha Jacob, Florence Phelanyane, Jonathan Euvrard, Juanita Arendse, Aurelie Nelson, Muzzammil Ismail, Andrew Boulle, et al.

    Background: In South Africa, HIV treatment guideline changes implemented in 2020 introduced dolutegravir-based regimens and expanded viral load (VL) monitoring to include testing at delivery and 6 months postpartum for women on antiretroviral therapy (ART). We assessed temporal trends and factors associated with VL monitoring and outcomes among pregnant and postpartum women with HIV in the Western Cape. Methods: We included women with HIV with live births from 2018-2024 who initiated ART before or during pregnancy. We used routinely-collected healthcare data to assess VL monitoring at (i) delivery or third trimester (“late pregnancy”), and (ii) postpartum (<8 months after delivery). VL categories were defined as <50, 50-999, and ≥1,000 copies/ml. We examined predictors of VL testing coverage and viral suppression using modified Poisson GEE and multinomial logistic regression models, including policy period, maternal age, parity, and ART timing . Results: Among 88,415 deliveries to 80,095 women: 74% received ART before pregnancy and 26% started ART during pregnancy. From 2018-2024, late-pregnancy VL testing coverage increased: 69%-91% (aRR=1.28, 95%CI 1.26-1.29); whereas postpartum testing coverage declined: 51%-43% (aRR=0.96, 95%CI 0.94-0.97). The proportion of women with late-pregnancy VL<50 increased from 73-80% (2018-2024), while VL 50-999 declined from 14%-8%. ART interruptions before or during pregnancy, younger age and higher parity were predictors of lower VL testing coverage and poorer virological outcomes. Conclusion: Updated ART guidelines improved late-pregnancy but not postpartum VL testing coverage. Dolutegravir introduction was associated with improved viral suppression <50 copies/ml. Persistently low postpartum coverage suggests substantial gaps in retention and/or VL testing.

  • Open Access

    Interest in long-acting injectable antiretroviral therapy (ART) among adults living with HIV newly starting or restarting ART in Cape Town, South Africa

    by Tamsin K. Phillips, Mpumelelo Zondo, Benjamin H. Chi, Lucia Knight, Thokozile Malaba, Landon Myer, Catherine Orrell

    Long-acting injectable antiretroviral therapy (LAI ART), specifically cabotegravir–rilpivirine (CAB/RPV), is safe and effective for maintaining viral suppression among people living with HIV (PLH) ...

  • Open Access

    “It’s not easy, but we need to support them so they don’t get tired on the way”: provider perspectives on delivering HIV services for people returning to HIV care in Cape Town, South Africa

    by Tamsin K. Phillips, Hannah Wolpe, Nasiphi Gwiji, Kate Clouse, Benjamin H. Chi, Suzanne Maman, Landon Myer, Lucia Knight

    Background: People living with HIV who interrupt treatment often face challenges when re-engaging in care and remain at risk for future interruptions. Understanding the provider perspective on the healthcare context in which re-engagement occurs is essential for designing effective and scalable support interventions. We aimed to characterize the implementation context for re-engaging in HIV care in Cape Town, South Africa, with a view to inform the design of future interventions in this setting. Methods: We conducted semi-structured in-depth interviews with nurses ( n = 5), counsellors ( n = 3) and administrative clerks ( n = 3) at two public-sector health facilities. Data collection and thematic analysis were guided by the inner setting of the Consolidated Framework for Implementation Research (CFIR), including structural characteristics, organizational culture, relational dynamics, and communication. Results: We identified compounding and interconnected challenges within the CFIR inner setting. Limited staffing and fragmented clinic organization contributed to delays and frustration for both clients of HIV services and providers, reinforcing negative client-provider interactions. Despite valuing person-centred care, providers struggled to uphold these principles amid high workloads and systemic pressures relating to physical, information system, and human resource infrastructure limitations. Additionally, a cross-cutting theme was the challenge of inter-facility transfers, driven by geographic mobility and stigmatizing clinic interactions. Difficulties in linking client information across clinics intersected with the structural and relational barriers, adding another layer of complexity to providing supportive care for people returning to HIV services. Conclusions: Providers in this context were empathetic but layered inner setting barriers made it challenging to provide person-centred care. Addressing these challenges requires interventions that not only accommodate the changing life circumstances of people living with HIV but crucially facility- and system-level changes to support the providers and their working environments, which together will foster strong reciprocal client-provider relationships. Future interventions must prioritize strengthening staffing and workload capacity, physical infrastructure, and information systems alongside simplified, responsive service delivery models to ease the path back into care for people living with HIV and their providers.

  • Open Access

    Retention in a low‐resource, high‐burden South African cohort on antiretroviral therapy: Retrospective, longitudinal analysis comparing six measures of retention

    by Claire M. Keene, Jonathan Euvrard, Tamsin K. Phillips, Mike English, Jacob McKnight, Catherine Orrell

    Introduction: Retention on antiretroviral therapy (ART) is a prerequisite for adherence and subsequent treatment success. Measuring retention is also easily implementable at facility and population levels, making it pragmatic to monitor ART programme success. However, despite its ubiquitous global use, there is little consistency in the measurement of retention. Methods: This study retrospectively applied six measures of retention to one cohort of adults (initiating ART after 01‐09‐2016, with ≥1 year of observation time to database closure on 30‐09‐2022), in a low‐resource, high HIV‐burden setting in South Africa. Using routine healthcare data from the Western Cape's Provincial Health Data Centre, loss to follow‐up (LTFU), fixed‐point retention, visit constancy, visit gaps, treatment interruptions and medication possession ratio (MPR) were described over 5 years from initiation. Individuals were considered “continuously retained” if they did not experience attrition throughout their observed follow‐up. Measures were compared using the proportion misassigned and Cohen's Kappa statistic. Results: The median age of the cohort ( n = 68,888) was 31 years (interquartile range [IQR] 26–38) at initiation, with 69% (47,631/68,888) female, and a median observed follow‐up of 4 years (IQR 3–5). Across different measures, retention was low, and declined over time. There was variable overlap; the proportion continuously retained throughout their observed follow‐up ranged from 60% (41,268/68,888 not LTFU) to 32% (22,381/68,888 MPR ≥80%). Retention by all measures was strongly associated with viral suppression. Conclusions: By all measures, large proportions of people in this setting were considered out of ART care during 5 years of observed follow‐up time from initiation. This makes retention a critical target for intervention to improve population‐level viral suppression and achieve epidemic control. Measuring longitudinal retention revealed that most people disengaged from ART care at some point after initiation. Certain measures of retention (e.g. treatment interruptions) identified people in and out of care with more granularity, whereas blunter measures (e.g. LTFU) misassigned individuals’ retention status and missed patterns of retention over time as people cycled in and out of care between points of measurement. Ultimately, the choice of measure depends on the purpose of the evaluation and on the data available, but, where possible, more granular measures are recommended.


  • Open Access

    Routine Electronic Mother-Infant Data (REMInD): A proof-of-Concept Data to Care Study to Support Retention in Maternal HIV Treatment and Infant HIV Testing in Cape Town, South Africa

    by Tamsin K. Phillips, Yolanda Gomba, Pheposadi Mogoba, Florence Phelanyane, Kim Anderson, Benjamin H. Chi, Kate Clouse, Mary-Ann Davies, Jonathan Euvrard, Lucia Knight, et al.

    Data to Care (D2C) strategies– using routine data to identify and re-engage people living with HIV who are not in care– have shown promise in high-income settings but remain underexplored in lower-resource and vertical HIV transmission prevention (VTP) contexts. In this prospective, single-arm, proof-of-concept study, we used facility-linked public sector electronic medical records (Provincial Health Data Centre [PHDC] data) to identify, validate and trace postpartum VTP gaps among 336 mothers living with HIV and their infants in Cape Town, South Africa (March 2021–April 2022). Of 302 observed gaps, 123 (41%) were false, while 179 (59%) were probable gaps affecting 133 mother-infant pairs. Overall, 16% of mothers did not link to HIV care within 12 weeks postpartum and 13% had ART dispensing gaps, while 10% and 17% of infants had no HIV test around 10 weeks and six months, respectively. Only 100 (56%) probable gaps were confirmed through telephonic tracing, with 47 mothers subsequently re-linked to care. Mobility, stigma, and employment challenges contributed to disengagement. While our D2C approach streamlined tracing efforts, re-engagement remained difficult. Strategies integrating D2C approaches with interventions addressing social determinants are needed.


  • Open Access

    Routine Electronic Mother-Infant Data (REMInD): a proof-of-concept Data to Care study to support retention in maternal HIV treatment and infant HIV testing in Cape Town, South Africa

    by Tamsin K. Phillips, Yolanda Gomba, Pheposadi Mogoba, Florence Phelanyane, Kim Anderson, Benjamin H. Chi, Kate Clouse, Mary-Ann Davies, Jonathan Euvrard, Lucia Knight, et al.

    Data to Care (D2C) strategies – using routine data to facilitate identification and linkage back to care of people living with HIV who are not in care – have shown promise in high-income settings but received little attention in lower resourced or vertical HIV transmission prevention (VTP) contexts. In this proof-of-concept study, we monitored existing linked electronic medical records in near real-time to identify key gaps in postpartum VTP steps among 336 mothers living with HIV and their infants in Cape Town, South Africa (recruited March 2021 – April 2022). We attempted to confirm observed gaps through source data systems and telephonic tracing, and facilitated re-engagement in care where needed. There were 302 gaps observed in the routine data; 123 (41%) were false gaps and 179 (59%) were considered probable gaps (133 mother-infant pairs). Overall, 54 mothers (16%) did not link to HIV care within 12 weeks of delivery, 43 mothers (13%) linked to care but had a gap in ART dispensing by nine months postpartum, 25 infants (10%) did not have an HIV test around 10 weeks and 57 (17%) had no HIV test around 6 months of age. Only 100 of the probable gaps (56%) could be confirmed through telephonic tracing and, of those, only 47 were successfully re-linked to care. Mobility and clinic transfer, fear of stigma and employment-related challenges were commonly reported reasons for gaps in VTP steps. This study highlights that linked routine data sources linking mother-infant pairs across health facilities has the potential to streamline tracing efforts; however, implementation is challenging and, even when gaps are identified, re-engagement in care may be difficult. Further research is needed to combine D2C strategies with interventions addressing broader social and structural determinants of health, and to tailor D2C strategies to fit available resources and data sources in low-resource settings.


  • Open Access

    ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013–2019): a retrospective cohort study

    by Tamsin Kate Phillips, Reshma Kassanjee, Nicola Maxwell, Kim Anderson, Leigh Johnson, Haroon Moolla, Landon Myer, Benjamin H. Chi, Jonathan Euvrard, Andrew Boulle, et al.

    Introduction: In recent years, the expansion of HIV treatment eligibility has resulted in an increase in people with antiretroviral therapy (ART) experience prior to pregnancy but little is known about postpartum engagement in care in this population. We examined differences in disengagement from HIV care after delivery by maternal ART history before conception.Methods: We analysed data from people living with HIV (aged 15–49) in Khayelitsha, South Africa, with ≥1 live birth between April 2013 and March 2019. We described trends over time in ART history prior to estimated conception, classifying ART history groups as: (A) on ART with no disengagement (>270 days with no evidence of HIV care); (B) returned before pregnancy following disengagement; (C) restarted ART in pregnancy after disengagement; and (D) ART new start in pregnancy. We used Kaplan–Meier curves and proportional‐hazards models (adjusted for maternal age, number of pregnancy records and year of delivery) to examine the time to disengagement from delivery to 2 years postpartum.Results: Among 7309 pregnancies (in 6680 individuals), the proportion on ART (A) increased from 19% in 2013 to 41% in 2019. The proportions of those who returned (B) and restarted (C) increased from 2% to 13% and from 2% to 10%, respectively. There was a corresponding decline in the proportion of new starts (D) from 77% in 2013 to 36% in 2019. In the first recorded pregnancy per person in the study period, 26% (95% CI 25–27%) had disengaged from care by 1 year and 34% (95% CI 33–36%) by 2 years postpartum. Individuals who returned (B: aHR 2.10, 95% CI 1.70–2.60), restarted (C: aHR 3.32, 95% CI 2.70–4.09) and newly started ART (D: aHR 2.41, 95% CI 2.12–2.74) had increased hazards of postpartum disengagement compared to those on ART (A).Conclusions: There is a growing population of people with ART experience prior to conception and postpartum disengagement varies substantially by ART history. Antenatal care presents an important opportunity to understand prior ART experiences and an entry into interventions for strengthened engagement in HIV care.


  • Peripartum mobility and maternal/child separation among women living with HIV in South Africa

    by Kate Clouse, Sandisiwe Noholoza, Sindiswa Madwayi, Megan Mrubata, Natalie N. Robbins, Carol S. Camlin, Landon Myer, Tamsin K. Phillips

    This prospective cohort study investigated the mobility patterns of 200 pregnant and postpartum women living with HIV in South Africa. Participants were enrolled during their third trimester from routine antenatal care near Cape Town, South Africa, and followed for six months postpartum. Quantitative data were collected at enrollment and follow-up. Mobility (self-reported) was common among the participants, despite the brief study period and the concurrent COVID-19 pandemic. While most reported stability in their current residence, 71% had a second main residence, primarily in the Eastern Cape (EC). Participants had a median of two lifetime moves, motivated by work, education, and family life. During the study period, 20% of participants met the study definition of travel (>7 days and >50 km), with trips predominantly to the EC, lasting a median duration of 30 days. Over one-third of participants with other living children reported that these children lived apart from them, with the mother's family being primary caregivers. These findings emphasize the need for targeted interventions to support continuity of care for mobile populations, particularly peripartum women living with HIV. The study contributes valuable insights into mobility dynamics and highlights unique barriers faced by this population, contributing to improved HIV care in resource-limited settings.

  • Open Access

    Smartphone Ownership and Usage Among Pregnant Women Living With HIV in South Africa: Secondary Analysis of CareConekta Trial Data

    by Sandisiwe Noholoza, Tamsin K Phillips, Sindiswa Madwayi, Megan Mrubata, Carol S Camlin, Landon Myer, Kate Clouse

    Background: Mobile health (mHealth) initiatives are increasingly common in low-resource settings, but the appropriateness of smartphone interventions in health care settings is uncertain. More research is needed to establish the appropriateness and feasibility of integrating new mHealth modalities (novel apps and social media apps) in the South African context. Objective: In this study, to inform future mHealth interventions, we describe smartphone ownership, preferences, and usage patterns among pregnant women living with HIV in Gugulethu, South Africa. Methods: We screened pregnant women living with HIV from December 2019 to February 2021 for the CareConekta trial. To be enrolled in the trial, respondents were required to be 18 years of age or older, living with HIV, ≥28 weeks pregnant, and own a smartphone that met the technical requirements of the CareConekta app. In this secondary analysis, we describe mobile phone ownership and sociodemographic characteristics of all women screened for eligibility (n=639), and smartphone use patterns among those enrolled in the trial (n=193). Results: Overall, median age was 31 (IQR 27-35) years. Of the 582 women who owned smartphones, 580 responded to the question about whether or not it was a smartphone, 2 did not. Among those with smartphones, 92% (421/458) of them used the Android operating system of version 5.0 or above, 98% (497/506) of phones had a GPS, and 96% (485/506) of individuals charged their phones less than twice a day. Among women who were enrolled in the trial, nearly all (99%, 190/193) owned the smartphone themselves; however, 14% (26/193) shared their smartphone with someone. In this case, 96% (25/26) reported possessing the phone most of the day. Median duration of ownership of the smartphone was 12 (IQR 5-24) months, median duration with current phone number use was 25 (IQR 12-60) months, and median number of cell phone numbers owned 2 years prior to enrollment in the trial was 2 (IQR 1-2). Receiving (192/193, 99.5%) and making (190/193, 99%) phone calls were among the most common smartphone uses. The least used features were GPS (106/193, 55%) and email (91/193, 47%). WhatsApp was most frequently reported as a favorite app (181/193, 94%). Conclusions: Smartphone ownership is very common among pregnant women living with HIV in this low-resource, periurban setting. Phone sharing was uncommon, nearly all used the Android system, and phones retained sufficient battery life. These results are encouraging to the development of mHealth interventions. Existing messaging platforms—particularly WhatsApp—are exceedingly popular and could be leveraged for interventions. Findings of moderate smartphone ownership turnover and phone number turnover are considerations for mHealth interventions in similar settings. Trial Registration: ClinicalTrials.gov NCT03836625; https://clinicaltrials.gov/ct2/show/NCT03836625?term=NCT03836625


  • Open Access

    The Implementation of a GPS-Based Location-Tracking Smartphone App in South Africa to Improve Engagement in HIV Care: Randomized Controlled Trial

    by Kate Clouse, Sandisiwe Noholoza, Sindiswa Madwayi, Megan Mrubata, Carol S Camlin, Landon Myer, Tamsin K Phillips

    Background: Mobile health interventions are common in public health settings in Africa, and our preliminary work showed that smartphones are increasing in South Africa. We developed a novel smartphone app—CareConekta—that used GPS location data to characterize personal mobility to improve engagement in HIV care among pregnant and postpartum women living with HIV in South Africa. The app also used the user’s location to map nearby clinics. Objective: We aimed to describe the feasibility, acceptability, and initial efficacy of using the app in a real-world setting. Methods: We conducted a prospective randomized controlled trial at a public sector clinic near Cape Town, South Africa. We enrolled 200 pregnant (third trimester) women living with HIV who owned a smartphone that met the required specifications. All participants installed the app, designed to collect 2 GPS heartbeats per day to geolocate the participant within a random 1-km fuzzy radius (for privacy). We randomized (1:1) participants to a control arm to receive the app with no additional support or an intervention arm to receive supportive phone calls, WhatsApp (Meta Platforms, Inc) messages, or both from the study team when traveling >50 km from the study area for >7 days. In addition to mobility data collected daily through the phone, participants completed questionnaires at enrollment and follow-up (approximately 6 months post partum). Results: A total of 7 participants were withdrawn at enrollment or shortly after because of app installation failure (6/200, 3%) or changing to an unsuitable phone (1/200, 0.50%). During the study period, no participant’s smartphone recorded at least 1 heartbeat per day, which was our primary feasibility measure. Of the 171 participants who completed follow-up, only half (91/171, 53.2%) reported using the same phone as that used at enrollment, with the CareConekta app still installed on the phone and GPS usually enabled. The top reasons reported for the lack of heartbeat data were not having mobile data, uninstalling the app, and no longer having a smartphone. Acceptability measures were positive, but participants at follow-up demonstrated a lack of understanding of the app’s purpose and function. The clinic finder was a popular feature. Owing to the lack of consistent GPS heartbeats throughout the study, we were unable to assess the efficacy of the intervention. Conclusions: Several key challenges impeded our study feasibility. Although the app was designed to reverse bill participants for any data use, the lack of mobile data was a substantial barrier to our study success. Participants reported purchasing WhatsApp data, which could not support the app. Problems with the web-based dashboard meant that we could not consistently monitor mobility. Our study provides important lessons about implementing an ambitious GPS-based study under real-world conditions in a limited-resource setting. Trial Registration: ClinicalTrials.gov NCT03836625; https://clinicaltrials.gov/ct2/show/NCT03836625 International Registered Report Identifier (IRRID): RR2-10.1186/s13063-020-4190-x